Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption

Overview of attention for article published in Cancer Letters, May 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 9 patents

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Chelated PSMA inhibitors

Grant CN-107325127-B

China

01 Sep 2020

Chelated PSMA inhibitors

Grant US-10166301-B2

United States of America

01 Jan 2019

ENGINEERED CELLS EXPRESSING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) OR A MODIFIED FORM…

Application WO-2018187791-A1

World Intellectual Property Organisation (WIPO)

11 Oct 2018

Chelated PSMA inhibitors

Grant US-9974869-B2

United States of America

22 May 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.